XTL Biopharmaceuticals Ltd.

Regulatory Filings • Jan 28, 2009

_________ false

C002��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996380Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 28/01/2009              Time of broadcast: 11:26 11:23:11

Reference: 2009-02-024216

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Copany received a Staff Determination Letter from Nasdaq notifying the Company that the Company's American Depository Shares ("ADRs") would be delisted from Nasdaq on February 5, 2009 unless the Company appeals within (7) calendar days, or until February 3, 2009. At this time, the Company does plan to appeal the delisting from Nasdaq. There can be no assurance that the appeal will be successful.
XTLNasdaqDelistJan09final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 31/12/2008
- - -
Name of the Signatory: : Kantor Ronen , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary , Name of Employer Company: .
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2